These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2935140)

  • 21. [Differences in the action of enkephalins, beta-endorphin, and morphine on spontaneous rhythmic movements of the isolated rabbit ileum].
    Beleslin DB; Terzić B; Samardzić R; Mićić D
    C R Seances Soc Biol Fil; 1984; 178(4):392-6. PubMed ID: 6098350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid peptidergic systems modulate the activity of beta-adrenergic mechanisms during memory consolidation processes.
    Introini-Collison IB; Baratti CM
    Behav Neural Biol; 1986 Sep; 46(2):227-41. PubMed ID: 3021111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible interaction between central cholinergic muscarinic and opioid peptidergic systems during memory consolidation in mice.
    Baratti CM; Introini IB; Huygens P
    Behav Neural Biol; 1984 Mar; 40(2):155-69. PubMed ID: 6732709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ACTH, epinephrine and Met-enkephalin on brain beta-endorphin-like immunoreactivity, and of ACTH, epinephrine, Met-enkephalin and naloxone on retention, in normal and in protein-malnourished rats.
    Perry ML; Netto CA; Izquierdo I
    Braz J Med Biol Res; 1990; 23(1):65-72. PubMed ID: 2167138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral and electrophysiological effects of peptides related to lipotropin (beta-LPH).
    de Wied D; Bohus B; van Ree JM; Urban I
    J Pharmacol Exp Ther; 1978 Mar; 204(3):570-80. PubMed ID: 204766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence that inhibition of nicotine-mediated catecholamine secretion from adrenal chromaffin cells by enkephalin, beta-endorphin, dynorphin (1-13), and opiates is not mediated via specific opiate receptors.
    Dean DM; Lemaire S; Livett BG
    J Neurochem; 1982 Mar; 38(3):606-14. PubMed ID: 6276506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Memory impairment induced by intraamygdala beta-endorphin is mediated by noradrenergic influences.
    Introini-Collison IB; Ford L; McGaugh JL
    Neurobiol Learn Mem; 1995 Mar; 63(2):200-5. PubMed ID: 7663894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enkephalins modulate differentiation of normal human keratinocytes in vitro.
    Nissen JB; Kragballe K
    Exp Dermatol; 1997 Oct; 6(5):222-9. PubMed ID: 9450624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enkephalin actions on avoidance conditioning may be related to adrenal medullary function.
    Martinez JL; Rigter H
    Behav Brain Res; 1982 Nov; 6(3):289-99. PubMed ID: 7171387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of opioid peptides in memory and learning.
    Izquierdo I; Dias RD; Souza DO; Carrasco MA; Elisabetsky E; Perry ML
    Behav Brain Res; 1980 Dec; 1(6):451-68. PubMed ID: 6266433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of ACTH, epinephrine, beta-endorphin, naloxone, and of the combination of naloxone or beta-endorphin with ACTH or epinephrine on memory consolidation.
    Izquierdo I; Dias RD
    Psychoneuroendocrinology; 1983; 8(1):81-7. PubMed ID: 6308701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stria terminalis lesions attenuate the effects of posttraining naloxone and beta-endorphin on retention.
    McGaugh JL; Introini-Collison IB; Juler RG; Izquierdo I
    Behav Neurosci; 1986 Dec; 100(6):839-44. PubMed ID: 2949763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
    Wu HE; Thompson J; Sun HS; Leitermann RJ; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 2004 Jul; 310(1):240-6. PubMed ID: 14999057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The enhancement of retention induced by vasopressin in mice may be mediated by an activation of central nicotinic cholinergic mechanisms.
    Faiman CP; de Erausquin GA; Baratti CM
    Behav Neural Biol; 1991 Sep; 56(2):183-99. PubMed ID: 1759940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retention impairment by posttraining epinephrine: role of state dependency and of endogenous opioid mechanisms.
    Izquierdo I; McGaugh JL
    Behav Neurosci; 1987 Dec; 101(6):778-81. PubMed ID: 2827704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a novel experience prior to training or testing on retention of an inhibitory avoidance response in mice: involvement of an opioid system.
    Izquierdo I; McGaugh JL
    Behav Neural Biol; 1985 Sep; 44(2):228-38. PubMed ID: 4062777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The in vitro and in vivo effects of enkephalins and beta-endorphin on ACE activity in mice.
    Koyuncuoğlu H; Enginar N; Hatipoğlu I
    Pharmacol Res Commun; 1986 Mar; 18(3):301-9. PubMed ID: 3014570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Motility effects of opioid peptides in dog intestine.
    Burks TF; Hirning LD; Galligan JJ; Davis TP
    Life Sci; 1982 Nov 15-22; 31(20-21):2237-40. PubMed ID: 6298519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naltrexone-sensitive behavioral actions of the ACTH 4-9 analog (Org 2766).
    Fekete M; Drago F; Van Ree JM; Bohus B; Wiegant VM; De Wied D
    Life Sci; 1983 May; 32(19):2193-204. PubMed ID: 6302425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methionine-enkephalin antagonism and endorphin potentiation of narcotic-induced analgesia.
    Chapman DB; Hu J; Way EL
    Eur J Pharmacol; 1980 Aug; 65(4):369-77. PubMed ID: 7190925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.